Core Alternative Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Core Alternative Capital's GILD Position: Q3 2026 in Review
Core Alternative Capital increased its Gilead Sciences (GILD) stake by 12% in Q3 2026, buying an estimated $35.5K and bringing the position to 2,442 shares worth $364K. The position accounts for 0.11% of the portfolio, ranked #96.
Core Alternative Capital first reported a position in GILD in Q4 2021 and has held it in 20 quarters since. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Core Alternative Capital held 2,442 shares of Gilead Sciences worth $364K as of Q3 2026.
- Core Alternative Capital bought 253 Gilead Sciences shares in Q3 2026, an estimated $35.5K.
- Gilead Sciences made up 0.11% of Core Alternative Capital's portfolio in Q3 2026, its #96 holding.
- Core Alternative Capital first reported a position in Gilead Sciences in Q4 2021 and has held it in 20 quarters since.
- 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Core Alternative Capital's 13F filing for Q3 2026, filed 12 Nov 2026.